MNNG.F Stock Overview

An investment holding company, engages in the purchase, process, design, production, and wholesale distribution of pearls and jewelry products. More details

MNNG.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($564M)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Baijin Life Science Holdings Limited Competitors

Kandal M Venture

NasdaqCM:FMFC

US$81.0m

Tefron

OTCPK:TFRF.F

US$94.6m

Vera Bradley

NasdaqGS:VRA

US$55.3m

Fossil Group

NasdaqGS:FOSL

US$58.4m

Price History & Performance

Summary of share price highs, lows and changes for Baijin Life Science Holdings
Historical stock prices
Current Share Price	HK$0.08
52 Week High	HK$0.08
52 Week Low	HK$0.04
Beta	0.0014
1 Month Change	33.33%
3 Month Change	n/a
1 Year Change	33.33%
3 Year Change	n/a
5 Year Change	3,900.00%
Change since IPO	-42.86%

Recent updates

Shareholder Returns

	MNNG.F	US Luxury	US Market
7D	0%	3.4%	2.8%
1Y	33.3%	-18.8%	9.3%

Return vs Industry: MNNG.F exceeded the US Luxury industry which returned -18.8% over the past year.

Return vs Market: MNNG.F exceeded the US Market which returned 9.3% over the past year.

Price Volatility

Is MNNG.F's price volatile compared to industry and market?
MNNG.F volatility
MNNG.F Average Weekly Movement	n/a
Luxury Industry Average Movement	9.1%
Market Average Movement	7.9%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	4.2%

Stable Share Price: MNNG.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MNNG.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	84	n/a	www.baijinlifescience.com

Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, process, design, production, and wholesale distribution of pearls and jewelry products. It operates through Sales of Pearls and Jewellery Products; Strategic Investment and Financial Services; Skincare Solutions; Research and Development Services; and Brand Marketing and Consulting Services segment. The company is also involved in the real estate financial assets investment business.

Baijin Life Science Holdings Limited Fundamentals Summary

How do Baijin Life Science Holdings's earnings and revenue compare to its market cap?
MNNG.F fundamental statistics
Market cap	US$72.75m
Earnings (TTM)	-US$1.47m
Revenue (TTM)	US$12.83m

5.7x

P/S Ratio

-49.6x

P/E Ratio

Is MNNG.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MNNG.F income statement (TTM)
Revenue	HK$99.46m
Cost of Revenue	HK$72.16m
Gross Profit	HK$27.29m
Other Expenses	HK$38.65m
Earnings	-HK$11.36m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.015
Gross Margin	27.44%
Net Profit Margin	-11.42%
Debt/Equity Ratio	46.8%

How did MNNG.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 13:38
End of Day Share Price	2025/04/23 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baijin Life Science Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.